Exceptional responses with sequential metronomic temozolomide after pembrolizumab failure in patients with metastatic melanoma

Overview of attention for article published in Melanoma Research, December 2019

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 304 followers.

Exceptional responses with sequential metronomic temozolomide after pembrolizumab failure in patients with metastatic melanoma https://t.co/fZ1UVqxqtx https://t.co/zjpxPmJDOr

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.